Clinical trial
Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in…
NCT00286273 · Onze Lieve Vrouwe Gasthuis, Other · Completed
Key facts
| NCT number | NCT00286273 |
|---|---|
| Title | Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration |
| Official title | Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration, a Randomized Controlled Trial Comparing Anticoagulation With Citrate to the Low Molecular Weight Heparin Nadroparin |
| Lead sponsor | Onze Lieve Vrouwe Gasthuis, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Acute |
| Intervention type | Drug |
| Interventions | trisodium citrate, nadroparin |
| Enrollment | 215 |
| Start date | Mar 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Feb 3, 2006 |
| Last update posted | Aug 26, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: